In simple terms, Purple Biotech Ltd. has 28.493 M shares that people are buying and selling right now.
Return on Investments
The company's asset efficiency, represented by a robust -0.449% return, is a testament to Purple Biotech Ltd.'s adeptness in optimizing resource deployment. Purple Biotech Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.490%. Furthermore, the proficiency of Purple Biotech Ltd. in capital utilization is underscored by a remarkable -0.323% return on capital employed.
Stock Prices
Purple Biotech Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.7396, while its low point bottomed out at $0.68. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Purple Biotech Ltd.'s stock market.
Liquidity Ratios
Analyzing PPBT liquidity ratios reveals its financial health of the firm.
The current ratio of 219.80% gauges short-term asset coverage for liabilities.
The quick ratio (214.56%) assesses immediate liquidity, while the cash ratio (201.71%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
219.80%
Quick Ratio
214.56%
Cash Ratio
201.71%
Profitability Ratios
The effective tax rate stands at 47.73%, revealing its tax efficiency.
The net income per EBT, 99.51%, and the EBT per EBIT, 166.46%, provide insights into its earnings hierarchy.
cards.indicator
cards.value
Effective Tax Rate
47.73%
Net Income per EBT
99.51%
EBT per EBIT
166.46%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 2.20, it details the span from stock purchase to revenue.
The 2 days it takes to settle debts showcases its creditor relations.
cards.indicator
cards.value
Days of Sales Outstanding
215
Days of Payables Outstanding
6544
Payables Turnover
0.06
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.81, and free cash flow per share, -0.81, depict cash generation on a per-share basis.
The cash per share value, 0.63, showcases liquidity position.
cards.indicator
cards.value
Operating Cash Flow per Share
-0.81
Free Cash Flow per Share
-0.81
Cash per Share
0.63
Free Cash Flow to Operating Cash Flow Ratio
1.00
Cash Flow Coverage Ratio
-56.58
Short Term Coverage Ratio
-105.63
Capital Expenditure Coverage Ratio
-6619.67
Dividend Paid and Capex Coverage Ratio
-6619.67
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 0.79%, highlights its total liabilities relative to assets.
With a debt-equity ratio of 0.01, we discern the balance between debt and equity financing.
The long-term debt to capitalization, 0.47%, and total debt to capitalization, 1.02%, ratios shed light on its capital structure.
An interest coverage of -5.47 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Debt Ratio
0.79%
Debt Equity Ratio
0.01
Long Term Debt to Capitalization
0.47%
Total Debt to Capitalization
1.02%
Interest Coverage
-5.47
Cash Flow to Debt Ratio
-56.58
Company Equity Multiplier
1.30
Per Share Data
Net income per share, -0.81, reflects the portion of profit attributed to each share.
The book value per share, 1.39, represents the net asset value distributed per share, while the tangible book value per share, 0.25, excludes intangible assets.
cards.indicator
cards.value
Net Income Per Share
-0.81
Book Value Per Share
1.39
Tangible Book Value Per Share
0.25
Shareholders Equity Per Share
1.39
Interest Debt Per Share
0.10
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 100.00%, indicates top-line expansion, while the gross profit growth, 82.09%, reveals profitability trends.
EBIT growth, 1.47%, and operating income growth, 1.47%, offer insights into operational profitability progression.
The net income growth, 4.54%, showcases bottom-line expansion, and the EPS growth, 28.32%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
100.00%
Gross Profit Growth
82.09%
EBIT Growth
1.47%
Operating Income Growth
1.47%
Net Income Growth
4.54%
EPS Growth
28.32%
EPS Diluted Growth
28.32%
Weighted Average Shares Growth
33.21%
Weighted Average Shares Diluted Growth
33.21%
Operating Cash Flow Growth
-14.88%
Free Cash Flow Growth
-13.36%
5-Year Revenue Growth per Share
-100.00%
3-Year Revenue Growth per Share
-100.00%
10-Year Operating CF Growth per Share
98.75%
5-Year Operating CF Growth per Share
-79.98%
3-Year Operating CF Growth per Share
-11.15%
10-Year Net Income Growth per Share
99.75%
5-Year Net Income Growth per Share
-203.49%
3-Year Net Income Growth per Share
-12.03%
10-Year Shareholders Equity Growth per Share
101.21%
5-Year Shareholders Equity Growth per Share
158.05%
3-Year Shareholders Equity Growth per Share
-69.88%
Asset Growth
-18.89%
Book Value per Share Growth
-45.26%
Debt Growth
-31.84%
R&D Expense Growth
4.38%
SGA Expenses Growth
-19.82%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 5,065,115.62, captures the company's total value, considering both debt and equity.
Income quality, 0.97, assesses the reliability of reported earnings.
The ratio of intangibles to total assets, 63.30%, indicates the value of non-physical assets, and capex to operating cash flow, 0.02%, measures reinvestment capability.
cards.indicator
cards.value
Enterprise Value
5,065,115.62
Income Quality
0.97
Intangibles to Total Assets
63.30%
Capex to Operating Cash Flow
0.02%
Capex to Depreciation
-1.51%
Graham Number
5.02
Return on Tangible Assets
-122.28%
Graham Net Net
0.22
Working Capital
8,605,000
Tangible Asset Value
6,253,000
Net Current Asset Value
5,783,000
Average Payables
2,832,000
Days Payables Outstanding
6478
ROIC
-64.13%
ROE
-0.58%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.37, and the price to book ratio, 0.37, reflect the market's valuation relative to the company's book value.
Ratios like price to free cash flows, -0.75, and price to operating cash flows, -0.63, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
0.37
Price to Book Ratio
0.37
Price Cash Flow Ratio
-0.63
Enterprise Value Multiple
-1.38
Price Fair Value
0.37
Price to Operating Cash Flow Ratio
-0.63
Price to Free Cash Flows Ratio
-0.75
Price to Tangible Book Ratio
0.56
Enterprise Value Over EBITDA
-0.23
EV to Operating Cash Flow
-0.26
Earnings Yield
-103.52%
Free Cash Flow Yield
-100.13%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
